Omnicell vs NCR Voyix
OMCL and VYX side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How OMCL and VYX compare
Omnicell is the larger company, worth 1.2 times as much as NCR Voyix ($1.6B against $1.3B).
On earnings, NCR Voyix is cheaper: it trades at 26.4× trailing earnings, against 40.0× for Omnicell.
Omnicell grew revenue faster over the last twelve months (8.5% versus −4.8% for NCR Voyix).
Omnicell keeps more of each dollar of sales as profit, with a net margin of 3.1% compared with 3.0% at NCR Voyix.
Omnicell scores higher on the StockData Score (13 against 7 for NCR Voyix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | OMCL | VYX |
|---|---|---|
| Size and price | ||
| Market cap | $1.6B | $1.3B |
| Share price | $34.00 | $9.76 |
| Change, 1 year | −3.2% | −9.5% |
| Change, 5 years | −80.8% | −75.9% |
| Beta (5Y) | 1.23 | 1.31 |
| Employees | 3,580 | 14K |
| StockData Score | ||
| Total score | 13 (better) | 7 |
| Valuation score | 5 (better) | 4 |
| Growth score | 2 (better) | 0 |
| Performance score | 1 | 1 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 40.0× | 26.4× (better) |
| P/S | 1.2× | 0.5× (better) |
| P/B | 1.2× (better) | 1.5× |
| EV/EBITDA | 9.4× | 9.0× (better) |
| P/FCF | 10.9× | – |
| FCF yield | 9.2% (better) | −2.1% |
| Fair value | $48.85 | $14.73 |
| Margin of safety | 30.4% | 33.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 8.5% (better) | −4.8% |
| Revenue growth, 5Y average | 5.8% (better) | −15.4% |
| Net income growth (TTM) | 69.3% (better) | −92.8% |
| EPS growth (TTM) | 70.0% (better) | −94.8% |
| EPS growth, 5Y average | −44.2% | – |
| Profitability | ||
| Gross margin | 44.8% | – |
| Operating margin | 4.6% (better) | 1.1% |
| Net margin | 3.1% (better) | 3.0% |
| FCF margin | 11.4% (better) | −1.1% |
| Return on equity | 3.1% | 8.5% (better) |
| Return on invested capital | 4.0% (better) | 1.2% |
| Financial health | ||
| Debt / equity | 0.00 | 1.19 (better) |
| Net debt / EBITDA | – | 3.51 |
| Interest coverage | – | 0.4× |
| Current ratio | 1.64 (better) | 1.07 |
| Altman Z-score | 2.50 (better) | 1.20 |
| Piotroski F-score | 7 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | 1.9% |
| Shareholder yield | 0.00% | 1.9% (better) |
| Ownership | ||
| Held by institutions | 106% | 117% |
| Held by insiders | 3.3% | 0.79% |
| Insider net buying, 12 months | −$2.9M | −$105K (better) |
| Short interest, % of float | 8.6% | – |
Go deeper
- OMCL stock overview
- OMCL income statement
- OMCL valuation and score
- VYX stock overview
- VYX income statement
- VYX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.